Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Empagliflozin Reduces Risk of Hospitalization in Patients With Chronic Kidney Disease in the EMPA-KIDNEY Trial
PaperCitations, authors & open-access status
Empagliflozin Reduces Risk of Hospitalization in Patients With Chronic Kidney Disease in the EMPA-KIDNEY Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 2 citations, 2025 year and hybrid oa status.
2
Citations
2025
Year
hybrid
OA Status